Current Value of Holding

$657k

Shares

340k

% of Portfolio

0.00%

Average Buy Price

$13.1

Avg closing price
Price range

23 PRIMECAP Management Health Catalyst Trades

PRIMECAP Management's position in Health Catalyst is currently worth $657k. That's 0.00% of their equity portfolio (305th largest holding). The first Health Catalyst trade was made in Q2 2020. Since then PRIMECAP Management bought shares sixteen more times and sold shares on six occasions. The investor's estimated purchase price is $4.47M, resulting in a loss of 85%.

Avg closing price
Price range
Sold 75.1% shares (-1.03M shares) Q4 2025
Avg closing price $2.74
Price range $2.03 - $3.46
Sold 31.1% shares (-618k shares) Q3 2025
Avg closing price $3.43
Price range $2.70 - $4.09
Sold 0.9% shares (-18.4k shares) Q2 2025
Avg closing price $3.92
Price range $3.58 - $4.52
Increased shares by 3.8% (+72.5k shares) Q1 2025
Avg closing price $5.33
Price range $3.97 - $7.42
Sold 19.6% shares (-472k shares) Q4 2024
Avg closing price $7.95
Price range $6.90 - $9.02
Increased shares by 1.1% (+25k shares) Q3 2024
Avg closing price $7.21
Price range $5.48 - $8.83
Increased shares by 14.7% (+305k shares) Q2 2024
Avg closing price $6.42
Price range $5.53 - $7.28
Increased shares by 46.1% (+655k shares) Q1 2024
Avg closing price $9.13
Price range $7.44 - $11.21
Increased shares by 26.7% (+299k shares) Q4 2023
Avg closing price $8.17
Price range $6.71 - $10.16
Increased shares by 86.3% (+519k shares) Q3 2023
Avg closing price $11.94
Price range $9.35 - $14.32
Increased shares by 1.9% (+11.1k shares) Q2 2023
Avg closing price $11.91
Price range $9.86 - $13.12
Increased shares by 25.2% (+119k shares) Q1 2023
Avg closing price $12.75
Price range $10.23 - $14.76
Sold 0.2% shares (-910 shares) Q4 2022
Avg closing price $9.65
Price range $6.47 - $11.32
Increased shares by 54.2% (+166k shares) Q3 2022
Avg closing price $13.24
Price range $9.30 - $18.27
Increased shares by 12.8% (+34.7k shares) Q2 2022
Avg closing price $17.05
Price range $11.79 - $27.63
Increased shares by 13.0% (+31.3k shares) Q1 2022
Avg closing price $28.37
Price range $20.67 - $40.33
Increased shares by 3.1% (+7.34k shares) Q4 2021
Avg closing price $45.57
Price range $36.68 - $54.02
Sold 0.0% shares (-106 shares) Q3 2021
Avg closing price $54.54
Price range $49.57 - $58.15
Increased shares by 5.0% (+11k shares) Q2 2021
Avg closing price $53.27
Price range $47.17 - $58.64
Increased shares by 120.0% (+121k shares) Q1 2021
Avg closing price $48.44
Price range $42.51 - $54.07

News about Health Catalyst Inc and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!